Highly metastatic claudin-low mammary cancers can originate from luminal epithelial cells
The cellular origin and oncogenic drivers promoting claudin-low breast cancer are undefined. Here, the authors report that the consistent activation of oncogenic RAS signaling, as well as regulators of EMT, play a crucial role in the cellular plasticity and maintenance of the mesenchymal and stem ce...
Main Authors: | Patrick D. Rädler, Barbara L. Wehde, Aleata A. Triplett, Hridaya Shrestha, Jonathan H. Shepherd, Adam D. Pfefferle, Hallgeir Rui, Robert D. Cardiff, Charles M. Perou, Kay-Uwe Wagner |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2021-06-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-021-23957-5 |
Similar Items
-
Janus Kinase 1 Plays a Critical Role in Mammary Cancer Progression
by: Barbara L. Wehde, et al.
Published: (2018-11-01) -
Dual recombinase action in the normal and neoplastic mammary gland epithelium
by: Patrick D. Rädler, et al.
Published: (2021-10-01) -
Autocrine IGF1 Signaling Mediates Pancreatic Tumor Cell Dormancy in the Absence of Oncogenic Drivers
by: Nirakar Rajbhandari, et al.
Published: (2017-02-01) -
Murine mammary tumor cells with a claudin-low genotype
by: Siwicky Megan D, et al.
Published: (2011-08-01) -
Paracrine Met signaling triggers epithelial–mesenchymal transition in mammary luminal progenitors, affecting their fate
by: Amandine Di-Cicco, et al.
Published: (2015-07-01)